StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)

Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –

Eton Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Eton Pharmaceuticals's gross margin for the twelve months ending Sep 30, 2026 was 69.2%. For fiscal 2025 it was 53.5%, against 60.0% the year before. The highest annual figure on record is 87.1% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202553.5%−6.6
FY2024Dec 31, 202460.0%−6.5
FY2023Dec 31, 202366.6%−0.8
FY2022Dec 31, 202267.4%−19.7
FY2021Dec 31, 202187.1%+1105.0
FY2020Dec 31, 2020-1017.9%−1070.7
FY2019Dec 31, 201952.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202676.5%+41.5
Q2 FY2026Jun 30, 202667.6%+4.6
Q1 FY2026Mar 31, 202660.7%+3.7
Q4 FY2025Dec 31, 202561.6%+6.0
Q3 FY2025Sep 30, 202535.0%−26.1
Q2 FY2025Jun 30, 202563.0%+1.0
Q1 FY2025Mar 31, 202557.1%−5.8
Q4 FY2024Dec 31, 202455.6%+6.0
Q3 FY2024Sep 30, 202461.0%−1.6
Q2 FY2024Jun 30, 202462.0%−18.7
Q1 FY2024Mar 31, 202462.9%−0.2
Q4 FY2023Dec 31, 202349.6%−25.2
Q3 FY2023Sep 30, 202362.6%−0.0
Q2 FY2023Jun 30, 202380.7%+18.0
Q1 FY2023Mar 31, 202363.1%+2.1
Q4 FY2022Dec 31, 202274.8%−19.1
Q3 FY2022Sep 30, 202262.7%+47.1
Q2 FY2022Jun 30, 202262.7%−31.6
Q1 FY2022Mar 31, 202261.0%−25.7
Q4 FY2021Dec 31, 202193.9%+549.5
Q3 FY2021Sep 30, 202115.6%+55.6
Q2 FY2021Jun 30, 202194.3%+97.4
Q1 FY2021Mar 31, 202186.6%+85.3
Q4 FY2020Dec 31, 2020-455.6%−555.6
Q2 FY2020Jun 30, 2020-40.0%–
Q1 FY2020Mar 31, 2020-3.0%–
Q4 FY2019Dec 31, 20191.3%–
Q1 FY2019Mar 31, 2019100.0%–

More Eton Pharmaceuticals figures

See a number that looks wrong?